文献速递技术与安全MR

β地中海贫血患者肝脏和心脏以外器官的定量MRI铁负荷评估:一项系统综述

Quantitative MRI iron load assessment in β-thalassemia patients beyond the liver and heart: A systematic review.
PubMed 文献 · Eur J Radiol · 2025-11-17

该系统综述纳入近10年27项研究,评估定量MRI测量β地中海贫血患者肝脏和心脏以外器官铁负荷的技术现状。约86%的研究采用T2*加权多回波梯度回波序列,ROI法T2*定量是最主要的图像分析方法;MRI铁负荷标志物与内分泌、代谢功能障碍及全身铁负荷显著相关,但诊断性能因数据有限且异质仅为一般至良好。

要点

  • 约86%的研究采用T2*加权多回波梯度回波序列评估肝脏和心脏以外器官的铁负荷。
  • 23项研究采用基于ROI的T2*定量,通过信号衰减曲线单指数拟合进行分析。
  • MRI铁负荷标志物与内分泌、代谢功能障碍及全身铁负荷显著相关,但诊断性能仅为一般至良好。

核心结论

  • T2*映射仍是铁定量的无创标准,未来研究应优先优化技术并标准化肝脏和心脏以外器官的诊断阈值。

研究设计与样本

  • 系统综述,检索MEDLINE、PubMed和Web of Science近10年文献,纳入采用定量MRI测量β地中海贫血患者铁浓度的研究。

关键影像表现/征象

  • 约86%的研究采用T2*加权多回波梯度回波序列检测铁的顺磁效应。
  • 基于ROI的T2*定量是最主要的图像分析方法,23项研究通过信号衰减曲线单指数拟合实现。

诊断标准与关键数值

  • MRI铁负荷标志物(T2*/R2*)对代谢结局显示有前景的敏感度,对内分泌和骨髓评估显示特异度,但诊断性能因数据有限且异质仅为一般至良好。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 因方法学异质性大,未进行Meta分析。
  • 诊断性能数据有限且异质,仅达一般至良好。
  • 未来研究应优先优化技术并标准化肝脏和心脏以外器官的诊断阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND/OBJECTIVES: Magnetic Resonance Imaging (MRI) is a non-invasive method for quantifying tissue iron in β-thalasssemia patients. Optimized T2*-weighted MRI provides validated liver and cardiac iron thresholds yet iron burden in other organs remains underexplored. This systematic review evaluates current quantitative MRI techniques used to assess iron load in β-thalassemia, emphasizing identifying gaps in organ-specific methodologies.

METHODS: We conducted a systematic search in MEDLINE, PubMed, and Web of Science limited to the last 10 years. Studies were included if they employed quantitative MRI to measure iron concentrations in β-thalassemia patients. Extracted data included patient characteristics, MRI sequences, image analysis methods, cut-offs, grading scales, clinical correlations, and measures of diagnostic accuracy. Meta-analysis was not performed due to substantial methodological heterogeneity.

RESULTS: Twenty-seven studies utilized quantitative MRI to assess iron in organs beyond the heart and liver. Approximately 86% employed T2*-weighted Multi-Echo Gradient Echo sequences, reflecting their widespread acceptance for detecting paramagnetic effects of iron. ROI-based T2* quantification was the predominant image analysis method, applied in 23 studies through mono-exponential fitting of signal decay curves. MRI-derived iron load markers (T2*/R2*) showed significant correlations with endocrine, metabolic dysfunctions and systemic iron burden. Despite promising sensitivity for metabolic outcomes and specificity for endocrine and marrow assessments, diagnostic performance remains only fair to good due to limited and heterogeneous data.

CONCLUSION: T2* mapping, remains the non-invasive standard for iron quantification. Future research should prioritize optimizing techniques and standardizing diagnostic thresholds across organs beyond the liver and heart to improve early detection and management of iron-overload-related dysfunctions.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Almuqbel MM, Abousrafa S, Omara W, et al. Quantitative MRI iron load assessment in β-thalassemia patients beyond the liver and heart: A systematic review. Eur J Radiol. 2025. PMID: 41260184. doi:10.1016/j.ejrad.2025.112537

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。